ACE |
Angiotensin converting enzyme |
AKI |
Acute kidney injury |
AQP-2 |
Aquaporin 2 |
AV3V |
Anteroventral third ventricle |
BP |
Blood pressure |
CB |
Carotid Body |
CKD |
Chronic kidney disease |
DKA |
Diabetic ketoacidosis |
DM |
Diabetes mellitus |
DPP4 |
Dipeptidyl peptidase-IV |
ECM |
Extracellular matrix |
EPO |
Erythropoietin |
ESRD |
End stage renal disease |
GFR |
Glomerular filtration rate |
GLUT2 |
Glucose transporter 2 |
GLUT-9 |
Glucose transporter 9 |
HF |
Heart failure |
HIF |
Hypoxia inducible factor |
HOMA |
Homeostasis model assessment |
IML |
Intermediolateral nucleus of spinal cord |
IS |
Indoxyl sulfate |
NHE3 |
Na+/H+ exchanger isoform 3 |
NKCC-2 |
Na-K-Cl cotransporter 2 |
OVLT |
Organum vasculosum laminae terminalis |
PAC |
Plasma aldosterone concentration |
PAG |
Periaqueductal gray |
PCS |
P-cresol sulfate |
PRA |
Plasma renin activity |
PT |
Proximal tubules |
PVN |
Paraventricular nucleus of hypothalamus |
RAS |
Renin-angiotensin system |
RCT |
Randomized clinical trials |
ROS |
Reactive oxygen species) |
RVLM |
Rostral ventrolateral medulla |
SGLT-2 |
Sodium–glucose cotransporter 2 |
SGLT2i |
Sodium–glucose cotransporter 2 inhibitor |
SIRT-1 |
Sirtulin-1 |
SNA |
Sympathetic nerve activity |
SNS |
Sympathetic nerve system |
T1DM |
Type 1 diabetes mellitus |
T2DM |
Type 2 diabetes mellitus |
TGF |
Tubular-glomerular feedback |
TGFβ |
Transforming growth factor β |
TNFα |
Tumor necrosis factor α |
VEGF |
Vascular endothelial growth factor |
VHL-E3 |
Von Hippel-Lindau ubiquitin ligase-E3 |
URAT1 |
Urate transporter 1 |